Expression of mineralocorticoid and glucocorticoid receptors in preautonomic neurons of the rat paraventricular nucleus

American Journal of Physiology - Regulatory Integrative and Comparative Physiology

Volumn 306, Issue 5, 2014, Pages

  Chen, Jian ^a   Gomez Sanchez, Celso E ^a,b,c   Penman, Alan ^a   May, Paul J ^a   Gomez Sanchez, Elise ^a,b,c  

^a UNIVERSITY OF MISSISSIPPI MEDICAL CENTER   (United States)

^b UNIVERSITY OF MISSISSIPPI SCHOOL OF MEDICINE   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

11 ; Aldosterone; Glucocorticoid receptor; Hydroxysteroid dehydrogenase; Mineralocorticoid receptor; Paraventricular nucleus; Preautonomic neuron; Sodium; Sympathetic nervous system

Indexed keywords

11BETA HYDROXYSTEROID DEHYDROGENASE 1; 11BETA HYDROXYSTEROID DEHYDROGENASE 2; ALDOSTERONE; CCAAT ENHANCER BINDING PROTEIN; CORTICOSTERONE; FLUOROGOLD; GLUCOCORTICOID RECEPTOR; GLUCOSE 6 PHOSPHATE DEHYDROGENASE; MINERALOCORTICOID RECEPTOR; NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; PROTEIN C FOS; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; SODIUM; TRACER; NFAT5 PROTEIN, RAT; TRANSCRIPTION FACTOR;

ADRENERGIC SYSTEM; ALDOSTERONE BLOOD LEVEL; ANIMAL CELL; ARTICLE; BRAIN REGION; CELL POPULATION; CELL SIZE; CONTROLLED STUDY; CORTICOSTERONE BLOOD LEVEL; ENZYME ACTIVITY; FEMALE; FLUORESCENCE; HIGH SODIUM INTAKE; HYPOTHALAMIC PARAVENTRICULAR NUCLEUS; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; NERVE CELL; NONHUMAN; PREAUTONOMIC NEURON; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SODIUM BLOOD LEVEL; SODIUM INTAKE; SODIUM RESTRICTION; WESTERN BLOTTING; 11-Β HYDROXYSTEROID DEHYDROGENASE; ADAPTATION; ANIMAL; ANIMAL FOOD; CLASSIFICATION; CYTOLOGY; DIET; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; METHODOLOGY; ONCOGENE; PARAVENTRICULAR NUCLEUS; PHYSIOLOGY;

11-Β HYDROXYSTEROID DEHYDROGENASE; ALDOSTERONE; GLUCOCORTICOID RECEPTOR; MINERALOCORTICOID RECEPTOR; PARAVENTRICULAR NUCLEUS; PREAUTONOMIC NEURON; SODIUM; SYMPATHETIC NERVOUS SYSTEM;

11-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 1; 11-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 2; ADAPTATION, PHYSIOLOGICAL; ANIMAL FEED; ANIMALS; DIET; GENE EXPRESSION REGULATION; GENES, FOS; IMMUNOHISTOCHEMISTRY; NEURONS; PARAVENTRICULAR HYPOTHALAMIC NUCLEUS; RATS; RECEPTORS, GLUCOCORTICOID; RECEPTORS, MINERALOCORTICOID; TRANSCRIPTION FACTORS;

EID: 84899428268     PISSN: 03636119     EISSN: 15221490     Source Type: Journal    
DOI: 10.1152/ajpregu.00506.2013     Document Type: Article

References (113)

1. Ahmed AH, Gordon RD, Taylor PJ, Ward G, Pimenta E, Stowasser M. Are women more at risk of false-positive primary aldosteronism screening and unnecessary suppression testing than men? J Clin Endocrinol Metab 96: E340-E346, 2011.
2. Atanasov AG, Nashev LG, Schweizer RA, Frick C, Odermatt A. Hexose-6-phosphate dehydrogenase determines the reaction direction of 11β-hydroxysteroid dehydrogenase type 1 as an oxoreductase. FEBS Lett 571: 129-133, 2004.
3. Boschitsch E, Mayerhofer S, Magometschnigg D. Hypertension in women: the role of progesterone and aldosterone. Climacteric 13: 307-313, 2010.
4. Bratton MR, Gomez-Sanchez EP, Gomez-Sanchez CE, Subauste JS. The myosin binding protein is a novel mineralocorticoid receptor binding partner. Mol Cell Endocrinol 217: 221-227, 2004.
5. Brinks V, van der Mark MH, de Kloet ER, Oitzl MS. Differential MR/GR activation in mice results in emotional states beneficial or impairing for cognition. Neural Plast 2007: 90163, 2007.
6. Brody MJ, Haywood JR, Touw KB. Neural mechanisms in hypertension. Ann Rev Physiol 42: 441-453, 1978.
7. Brody MJ, Varner KJ, Vasquez EC, Lewis SJ. Central nervous system and the pathogenesis of hypertension. Sites and Mechanisms. Hypertension 18: III7-III12, 1991.
8. Bujalska IJ, Draper N, Michailidou Z, Tomlinson JW, White PC, Chapman KE, Walker EA, Stewart PM. Hexose-6-phosphate dehydrogenase confers oxo-reductase activity upon 11 β-hydroxysteroid dehydrogenase type 1. J Mol Endocrinol 34: 675-684, 2005.
9. Burton PJ, Krozowski ZS, Waddell BJ. Immunolocalization of 11betahydroxysteroid dehydrogenase types 1 and 2 in rat uterus: variation across the estrous cycle and regulation by estrogen and progesterone. Endocrinology 139: 376-382, 1998.
10. Carillo BA, Oliveira-Sales EB, Andersen M, Tufik S, Hipolide D, Santos AA, Tucci PJ, Bergamaschi CT, Campos RR. Changes in GABAergic inputs in the paraventricular nucleus maintain sympathetic vasomotor tone in chronic heart failure. Auton Neurosci 171: 41-48, 2012.
11. Chapman K, Holmes M, Seckl J. 11β-hydroxysteroid dehydrogenases: intracellular gate-keepers of tissue glucocorticoid action. Physiol Rev 93: 1139-1206, 2013.
12. Cornelisse S, Joels M, Smeets T. A randomized trial on mineralocorticoid receptor blockade in men: effects on stress responses, selective attention, and memory. Neuropsychopharmacology 36: 2720-2728, 2011.
13. De Kloet ER. Brain corticosteroid receptor balance and homeostatic control. Front Neuroendocrinol 12: 95-164, 1991.
14. de Kloet ER, Karst H, Joels M. Corticosteroid hormones in the central stress response: quick-and-slow. Front Neuroendocrinol 29: 268-272, 2008.
15. de Souza LM, Franci CR. Differential immunoreactivity of glucocorticoid receptor and GABA in GABAergic afferents to parvocellular neurons in the paraventricular nucleus. Neurosci Lett 534: 199-204, 2013.
16. Dinicolantonio JJ, Niazi AK, Sadaf R, JHOK, Lucan SC, Lavie CJ. Dietary sodium restriction: take it with a grain of salt. Am J Med 126: 951-955, 2013.
17. Dustan HP. Relationship of sodium sensitivity and the sympathetic nervous system. J Cardiovasc Pharmacol 7 Suppl 8: S56-S63, 1985.
18. Edwards CRW, Burt D, McIntyre MA, De Kloet ER, Stewart PM, Brett L, Sutanto WS, Monder C. Localisation of 11β-hydroxysteroid dehydrogenase-tissue specific protector of the mineralocorticoid receptor. Lancet 2: 986-989, 1988.
19. Farman N, Rafestin-Oblin ME. Multiple aspects of mineralocorticoid selectivity. Am J Physiol Renal Physiol 280: F181-F192, 2001.
20. Felder RB. Mineralocorticoid receptors, inflammation and sympathetic drive in a rat model of systolic heart failure. Exp Physiol 95: 19-25, 2010.
21. Ferguson AV, Latchford KJ, Samson WK. The paraventricular nucleus of the hypothalamus-a potential target for integrative treatment of autonomic dysfunction. Expert Opin Ther Targets 12: 717-727, 2008.
22. Funder JW. Mineralocorticoid receptor activation and oxidative stress. Hypertension 50: 840-841, 2007.
23. Galigniana MD, Harrell JM, Murphy PJ, Chinkers M, Radanyi C, Renoir JM, Zhang M, Pratt WB. Binding of hsp90-associated immunophilins to cytoplasmic dynein: direct binding and in vivo evidence that the peptidylprolyl isomerase domain is a dynein interaction domain. Biochemistry 41: 13602-13610, 2002.
24. Galigniana MD, Scruggs JL, Herrington J, Welsh MJ, Carter-Su C, Housley PR, Pratt WB. Heat shock protein 90-dependent (geldanamycin-inhibited) movement of the glucocorticoid receptor through the cytoplasm to the nucleus requires intact cytoskeleton. Mol Endocrinol 12: 1903-1913, 1998.
25. Geerling JC, Chimenti PC, Loewy AD. Phox2b expression in the aldosterone-sensitive HSD2 neurons of the NTS. Brain Res 1226: 82-88, 2008.
26. Geerling JC, Kawata M, Loewy AD. Aldosterone-sensitive neurons in the rat central nervous system. J Comp Neurol 494: 515-527, 2006.
27. Geerling JC, Loewy AD. Aldosterone in the brain. Am J Physiol Renal Physiol 297: F559-F576, 2009.
28. Geerling JC, Loewy AD. Sodium deprivation and salt intake activate separate neuronal subpopulations in the nucleus of the solitary tract and the parabrachial complex. J Comp Neurol 504: 379-403, 2007.
29. Gekle M, Silbernagl S, Wunsch S. Non-genomic action of the mineralocorticoid aldosterone on cytosolic sodium in cultured kidney cells. J Physiol 511: 255-263, 1998.
30. Gennari-Moser C, Khankin EV, Escher G, Burkhard F, Frey BM, Karumanchi SA, Frey FJ, Mohaupt MG. Vascular endothelial growth factor-A and aldosterone: relevance to normal pregnancy and preeclampsia. Hypertension 61: 1111-1117, 2013.
31. Gomez-Sanchez CE, de Rodriguez AF, Romero DG, Estess J, Warden MP, Gomez-Sanchez MT, Gomez-Sanchez EP. Development of a panel of monoclonal antibodies against the mineralocorticoid receptor. Endocrinology 147: 1343-1348, 2006.
32. Gomez-Sanchez CE, Warden M, Gomez-Sanchez MT, Hou X, Gomez-Sanchez EP. Diverse immunostaining patterns of mineralocorticoid receptor monoclonal antibodies. Steroids 76: 1541-1545, 2011.
33. Gomez-Sanchez CE, Zhou MY, Cozza EN, Morita H, Eddleman FC, Gomez-Sanchez EP. Corticosteroid synthesis in the central nervous system. Endocr Res 22: 463-470, 1996.
34. Gomez-Sanchez CE, Zhou MY, Cozza EN, Morita H, Foecking MF, Gomez-Sanchez EP. Aldosterone biosynthesis in the rat brain. Endocrinology 138: 3369-3373, 1997.
35. Gomez-Sanchez EP. Intracerebroventricular infusion of aldosterone induces hypertension in rats. Endocrinology 118: 819-823, 1986.
36. Gomez-Sanchez EP. The mammalian mineralocorticoid receptor: tying down a promiscuous receptor. Exp Physiol 95: 13-18, 2010.
37. Gomez-Sanchez EP, Ahmad N, Romero DG, Gomez-Sanchez CE. Is aldosterone synthesized within the rat brain? Am J Physiol Endocrinol Metab 288: E342-E346, 2005.
38. Gomez-Sanchez EP, Ahmad N, Romero DG, Gomez-Sanchez CE. Origin of aldosterone in the rat heart. Endocrinology 145: 4796-4802, 2004.
39. Gomez-Sanchez EP, Fort CM, Gomez-Sanchez CE. Intracerebroventricular infusions of RU28318 blocks aldosterone-salt hypertension. Am J Physiol Endocrinol Metab 258: E482-E484, 1990.
40. Gomez-Sanchez EP, Ganjam V, Chen YJ, Liu Y, Zhou MY, Toroslu C, Romero DG, Hughson MD, de Rodriguez A, Gomez-Sanchez CE. Regulation of 11 β-hydroxysteroid dehydrogenase enzymes in the rat kidney by estradiol. Am J Physiol Endocrinol Metab 285: E272-E279, 2003.
41. Gomez-Sanchez EP, Gomez-Sanchez CE. 19-Nordeoxycorticosterone excretion in male and female inbred salt-sensitive (S/JR) and saltresistant (R/JR) rats. Endocrinology 122: 1110-1113, 1988.
42. Gomez-Sanchez EP, Gomez-Sanchez CE. 19-Nordeoxycorticosterone, aldosterone and corticosterone excretion in sequential urine samples of male and female rats. Steroids 56: 451-454, 1991.
43. Gomez-Sanchez EP, Gomez-Sanchez CE. Central Hypertensinogenic effects of glycyrrhizic acid and carbenoxolone. Am J Physiol Endocrinol Metab 263: E1125-E1130, 1992.
44. Gomez-Sanchez EP, Gomez-Sanchez CE. Central regulation of blood pressure by the mineralocorticoid receptor. Mol Cell Endocrinol 350: 289-298, 2012.
45. Gomez-Sanchez EP, Gomez-Sanchez CE. The effect of gonadectomy and aromatase inhibition on the excretion of 19-nordeoxycorticosterone in rats. J Steroid Biochem Mol Biol 39: 185-188, 1991.
46. Gomez-Sanchez EP, Gomez-Sanchez CE. Maternal hypertension and progeny blood pressure: role of aldosterone and 11β-HSD. Hypertension 33: 1369-1373, 1999.
47. Gomez-Sanchez EP, Gomez-Sanchez MT, de Rodriguez AF, Romero DG, Warden MP, Plonczynski MW, Gomez-Sanchez CE. Immunohistochemical demonstration of the mineralocorticoid receptor, 11β-hydroxysteroid dehydrogenase-1 and-2, and hexose-6-phosphate dehydrogenase in rat ovary. J Histochem Cytochem 57: 633-641, 2009.
48. Gomez-Sanchez EP, Romero DG, de Rodriguez AF, Warden MP, Krozowski Z, Gomez-Sanchez CE. Hexose-6-phosphate dehydrogenase and 11β-hydroxysteroid dehydrogenase-1 tissue distribution in the rat. Endocrinology 149: 525-533, 2008.
49. Gomez-Sanchez EP, Samuel J, Vergara G, Ahmad N. Effect of 3β-hydroxysteroid dehydrogenase inhibition by trilostane on blood pressure in the Dahl salt-sensitive rat. Am J Physiol Regul Integr Comp Physiol 288: R389-R393, 2005.
50. Gomez-Sanchez EP, Venkataraman MT, Thwaites D. ICV infusion of Corticosterone antagonizes ICV-aldosterone hypertension. Am J Physiol Endocrinol Metab 258: E649-E653, 1990.
51. Gordon RD, Kuchel O, Liddle GW, Island DP. Role of the sympathetic nervous system in regulating renin and aldosterone production in man. J Clin Invest 46: 599-605, 1967.
52. Gougeon R, Mitchell TH, Lariviere F, Abraham G, Montambault M, Marliss EB. Effects of sodium supplementation during energy restriction on plasma norepinephrine levels in obese women. J Clin Endocrinol Metab 73: 975-981, 1991.
53. Gray MJ, Strausfeld KS, Watanabe M, Sims EA, Solomon S. Aldosterone secretory rates in the normal menstrual cycle. J Clin Endocrinol Metab 28: 1269-1275, 1968.
54. Grossmann C, Ruhs S, Langenbruch L, Mildenberger S, Stratz N, Schumann K, Gekle M. Nuclear shuttling precedes dimerization in mineralocorticoid receptor signaling. Chem Biol 19: 742-751, 2012.
55. Hadoke PW, Kipari T, Seckl JR, Chapman KE. Modulation of 11β-hydroxysteroid dehydrogenase as a strategy to reduce vascular inflammation. Curr Atheroscler Rep 15: 320, 2013.
56. Han F, Ozawa H, Matsuda K, Nishi M, Kawata M. Colocalization of mineralocorticoid receptor and glucocorticoid receptor in the hippocampus and hypothalamus. Neurosci Res 51: 371-381, 2005.
57. Hawkins UA, Gomez-Sanchez EP, Gomez-Sanchez CM, Gomez-Sanchez CE. The ubiquitous mineralocorticoid receptor: clinical implications. Curr Hypertens Rep 14: 573-580, 2012.
58. Haywood JR, Brennan TJ, Hinojosa C. Neurohumoral mechanisms of sodium-dependent hypertension. Fed Proc 44: 2393-2399, 1985.
59. Hollis G, Huber R. 11β-Hydroxysteroid dehydrogenase type 1 inhibition in type 2 diabetes mellitus. Diabetes Obes Metab 13: 1-6, 2011.
60. Honrath U, Veress AT, Chong CK, Sonnenberg H. Effect of sympathetic and angiotensin-aldosterone systems on renal salt conservation in the rat. Am J Physiol Renal Physiol 272: F538-F544, 1997.
61. Janiak PC, Lewis SJ, Brody MJ. Role of central mineralocorticoid binding sites in development of hypertension. Am J Physiol Regul Integr Comp Physiol 259: R1025-R1034, 1990.
62. Joels M. Corticosteroid actions in the hippocampus. J Neuroendocrinol 13: 657-669, 2001.
63. Joels M, Karst H, DeRijk R, de Kloet ER. The coming out of the brain mineralocorticoid receptor. Trends Neurosci 31: 1-7, 2008.
64. Kaufman LJ, Vollmer RR. Low sodium diet augments plasma and tissue catecholamine levels in pithed rats. Clin Exp Hypertens A 6: 1543-1558, 1984.
65. Kiss JZ, Martos J, Palkovits M. Hypothalamic paraventricular nucleus: a quantitative analysis of cytoarchitectonic subdivisions in the rat. J Comp Neurol 313: 563-573, 1991.
66. Kovacs KJ. c-Fos as a transcription factor: a stressful (re)view from a functional map. Neurochem Int 33: 287-297, 1998.
67. Krozowski Z, Li KX, Koyama K, Smith RE, Obeyesekere VR, Stein-Oakley A, Sasano H, Coulter C, Cole T, Sheppard KE. The type I and type II 11β-hydroxysteroid dehydrogenase enzymes. J Ster Biochem Mol Biol 69: 391-401, 1999.
68. Lan CT, Wu WC, Ling EA, Chai CY. Evidence of a direct projection from the cardiovascular-reactive dorsal medulla to the intermediolateral cell column of the spinal cord in cats as revealed by light and electron microscopy. Neuroscience 77: 521-533, 1997.
69. Lenders JW, Golczynska A, Goldstein DS. Glucocorticoids, sympathetic activity, and presynaptic alpha 2-adrenoceptor function in humans. J Clin Endocrinol Metab 80: 1804-1808, 1995.
70. Lombes M, Kenouch S, Souque A, Farman N, Rafestin-Oblin M.-E. The mineralocorticoid receptor discriminates aldosterone from glucocorticoids independently of the 11β-hydroxysteroid dehydrogenase. Endocrinology 135: 834-840, 1994.
71. Lu B, Yang XJ, Chen K, Yang DJ, Yan JQ. Dietary sodium deprivation evokes activation of brain regional neurons and down-regulation of angiotensin II type 1 receptor and angiotensin-convertion enzyme mRNA expression. Neuroscience 164: 1303-1311, 2009.
72. Luft FC, Weinberger MH, Grim CE, Henry DP, Fineberg NS. Nocturnal urinary electrolyte excretion and its relationship to the renin system and sympathetic activity in normal and hypertensive man. J Lab Clin Med 95: 395-406, 1980.
73. Macefield VG, Williamson PM, Wilson LR, Kelly JJ, Gandevia SC, Whitworth JA. Muscle sympathetic vasoconstrictor activity in hydrocortisone-induced hypertension in humans. Blood Pressure 7: 215-222, 1998.
74. Martinerie L, Munier M, Le Menuet D, Meduri G, Viengchareun S, Lombes M. The mineralocorticoid signaling pathway throughout development: expression, regulation and pathophysiological implications. Biochimie 95: 148-157, 2013.
75. McGimsey WC, Cidlowski JA, Stumpf WE, Sar M. Immunocytochemical localization of the glucocorticoid receptor in rat brain, pituitary, liver, and thymus with two new polyclonal antipeptide antibodies. Endocrinology 129: 3064-3072, 1991.
76. Miller RL, Wang MH, Gray PA, Salkoff LB, Loewy AD. ENaCexpressing neurons in the sensory circumventricular organs become c-Fos activated following systemic sodium changes. Am J Physiol Regul Integr Comp Physiol 305: R1141-R1152, 2013.
77. Munier M, Meduri G, Viengchareun S, Leclerc P, Le Menuet D, Lombes M. Regulation of mineralocorticoid receptor expression during neuronal differentiation of murine embryonic stem cells. Endocrinology 151: 2244-2254, 2010.
78. Naumann T, Hartig W, Frotscher M. Retrograde tracing with Fluoro-Gold: different methods of tracer detection at the ultrastructural level and neurodegenerative changes of back-filled neurons in long-term studies. J Neurosci Methods 103: 11-21, 2000.
79. Nishi M, Tanaka M, Matsuda K, Sunaguchi M, Kawata M. Visualization of glucocorticoid receptor and mineralocorticoid receptor interactions in living cells with GFP-based fluorescence resonance energy transfer. J Neurosci 24: 4918-4927, 2004.
80. Nunn N, Womack M, Dart C, Barrett-Jolley R. Function and pharmacology of spinally-projecting sympathetic pre-autonomic neurones in the paraventricular nucleus of the hypothalamus. Curr Neuropharmacol 9: 262-277, 2011.
81. Otte C, Moritz S, Yassouridis A, Koop M, Madrischewski AM, Wiedemann K, Kellner M. Blockade of the mineralocorticoid receptor in healthy men: effects on experimentally induced panic symptoms, stress hormones, and cognition. Neuropsychopharmacology 32: 232-238, 2007.
82. Pascual-Le Tallec L, Lombes M. The mineralocorticoid receptor: a journey exploring its diversity and specificity of action. Mol Endocrinol 19: 2211-2221, 2005.
83. Pearce D, Naray-Fejes-Toth A, Fejes-Toth G. Determinants of subnuclear organization of mineralocorticoid receptor characterized through analysis of wild type and mutant receptors. J Biol Chem 277: 1451-1456, 2002.
84. Pilipuk GP, Vinson GP, Gomez-Sanchez CE, Galigniana MD. Evidence for NL1-independent nuclear translocation of the mineralocorticoid receptor. Biochemistry 46: 1389-1397, 2007.
85. Pitchers KK, Frohmader KS, Vialou V, Mouzon E, Nestler EJ, Lehman MN, Coolen LM. DeltaFosB in the nucleus accumbens is critical for reinforcing effects of sexual reward. Genes Brain Behav 9: 831-840, 2010.
86. Pitt B. Effect of aldosterone blockade in patients with systolic left ventricular dysfunction: implications of the RALES and EPHESUS studies. Mol Cell Endocrinol 217: 53-58, 2004.
87. Pyner S. Neurochemistry of the paraventricular nucleus of the hypothalamus: implications for cardiovascular regulation. J Chem Neuroanat 38: 197-208, 2009.
88. Pyner S, Coote JH. Identification of branching paraventricular neurons of the hypothalamus that project to the rostroventrolateral medulla and spinal cord. Neuroscience 100: 549-556, 2000.
89. Qi XR, Kamphuis W, Wang S, Wang Q, Lucassen PJ, Zhou JN, Swaab DF. Aberrant stress hormone receptor balance in the human prefrontal cortex and hypothalamic paraventricular nucleus of depressed patients. Psychoneuroendocrinology 38: 863-870, 2012.
90. Raheja P, Price A, Wang Z, Arbique D, Adams-Huet B, Auchus RJ, Vongpatanasin W. Spironolactone prevents chlorthalidone-induced sympathetic activation and insulin resistance in hypertensive patients. Hypertension 60: 319-325, 2012.
91. Roland BL, Krozowski ZS, Funder JW. Glucocorticoid receptor, mineralocorticoid receptors, 11β-hydroxysteroid dehydrogenase-1 and-2 expression in rat brain and kidney: in situ studies. Mol Cell Endocrinol 111: R1-R7, 1995.
92. Seckl JR, Yau J, Holmes M. 11β-hydroxysteroid dehydrogenases: a novel control of glucocorticoid action in the brain. Endocr Res 28: 701-707, 2002.
93. Shafton AD, Ryan A, Badoer E. Neurons in the hypothalamic paraventricular nucleus send collaterals to the spinal cord and to the rostral ventrolateral medulla in the rat. Brain Res 801: 239-243, 1998.
94. Shin SY, Han TH, Lee SY, Han SK, Park JB, Erdelyi F, Szabo G, Ryu PD. Direct corticosteroid modulation of GABAergic neurons in the anterior hypothalamic area of GAD65-eGFP mice. Korean J Physiol Pharmacol 15: 163-169, 2011.
95. Stewart PM, Murry BA, Mason JI. Human kidney 11β-hydroxysteroid dehydrogenase is a high-affinity nicotinamide adenine dinucleotide dependent enzyme and differs from the cloned type I isoform. J Clin Endocrinol Metab 79: 480-484, 1994.
96. Stocker SD, Madden CJ, Sved AF. Excess dietary salt intake alters the excitability of central sympathetic networks. Physiol Behav 100: 519-524, 2010.
97. Swanson LW. Brain Maps, Structure of the Rat Brain. Amsterdam: Elsevier, 1998.
98. Swanson LW, Kuypers HG. The paraventricular nucleus of the hypothalamus: cytoarchitectonic subdivisions and organization of projections to the pituitary, dorsal vagal complex, and spinal cord as demonstrated by retrograde fluorescence double-labeling methods. J Comp Neurol 194: 555-570, 1980.
99. Swanson LW, Sawchenko PE. Paraventricular nucleus: a site for the integration of neuroendocrine and autonomic mechanisms. Neuroendocrinology 31: 410-417, 1980.
100. Swanson LW, Sawchenko PE, Berod A, Hartman BK, Helle KB, Vanorden DE. An immunohistochemical study of the organization of catecholaminergic cells and terminal fields in the paraventricular and supraoptic nuclei of the hypothalamus. J Comp Neurol 196: 271-285, 1981.
101. Tasker JG. Rapid glucocorticoid actions in the hypothalamus as a mechanism of homeostatic integration. Obesity 14 Suppl 5: 259S-265S, 2006.
102. Thomas MC, Moran J, Forsblom C, Harjutsalo V, Thorn L, Ahola A, Waden J, Tolonen N, Saraheimo M, Gordin D, Groop PH. The association between dietary sodium intake, ESRD, and all-cause mortality in patients with type 1 diabetes. Diabetes Care 34: 861-866, 2011.
103. Viengchareun S, Kamenicky P, Teixeira M, Butlen D, Meduri G, Blanchard-Gutton N, Kurschat C, Lanel A, Martinerie L, Sztal-Mazer S, Blot-Chabaud M, Ferrary E, Cherradi N, Lombes M. Osmotic stress regulates mineralocorticoid receptor expression in a novel aldosterone-sensitive cortical collecting duct cell line. Mol Endocrinol 23: 1948-1962, 2009.
104. Vitiello MV, Prinz PN, Halter JB. Sodium-restricted diet increases nighttime plasma norepinephrine and impairs sleep patterns in man. J Clin Endocrinol Metab 56: 553-556, 1983.
105. Wang J, Li X, Ke Y, Lu Y, Wang F, Fan N, Sun H, Zhang H, Liu R, Yang J, Ye L, Liu M, Ning G. GPR48 increases mineralocorticoid receptor gene expression. J Am Soc Nephrol 23: 281-293, 2012.
106. Ward KR, Bardgett JF, Wolfgang L, Stocker SD. Sympathetic response to insulin is mediated by melanocortin 3/4 receptors in the hypothalamic paraventricular nucleus. Hypertension 57: 435-441, 2011.
107. Xue B, Badaue-Passos D Jr, Guo F, Gomez-Sanchez CE, Hay M, Johnson AK. Sex differences and central protective effect of 17-estradiol in the development of aldosterone/NaCl-induced hypertension. Am J Physiol Heart Circ Physiol 296: H1577-H1585, 2009.
108. Xue B, Beltz TG, Yu Y, Guo F, Gomez-Sanchez CE, Hay M, Johnson AK. Central interactions of aldosterone and angiotensin II in aldosteroneand angiotensin II-induced hypertension. Am J Physiol Heart Circ Physiol 300: H555-H564, 2011.
109. Yongue BG, Roy EJ. Endogenous aldosterone and corticosterone in brain cell nuclei of adrenal-intact rats: regional distribution and effects of physiological variations in serum steroids. Brain Res 436: 49-61, 1987.
110. Youm JK, Park K, Uchida Y, Chan A, Mauro TM, Holleran WM, Elias PM. Local blockade of glucocorticoid activation reverses stressand glucocorticoid-induced delays in cutaneous wound healing. Wound Repair Regen 21: 715-722, 2013.
111. Zhang ZH, Kang YM, Yu Y, Wei SG, Schmidt TJ, Johnson AK, Felder RB. 11β-hydroxysteroid dehydrogenase type 2 activity in hypothalamic paraventricular nucleus modulates sympathetic excitation. Hypertension 48: 127-133, 2006.
112. Zhang ZH, Yu Y, Wei SG, Felder RB. Centrally administered lipopolysaccharide elicits sympathetic excitation via NAD(P)H oxidasedependent mitogen-activated protein kinase signaling. J Hypertens 28: 806-816, 2010.
113. Zhu X, Manning RD Jr, Lu D, Gomez-Sanchez CE, Fu Y, Juncos LA, Liu R. Aldosterone stimulates superoxide production in macula densa cells. Am J Physiol Renal Physiol 301: F529-F535, 2011.